ProCE Banner Activity

Strategies for Optimal HIV Treatment and Prevention: Considering Cabotegravir in Pregnancy

Slideset Download
See available data and recommendations for the use of long-acting cabotegravir in pregnancy, as well as key considerations for deciding whether to switch ART for someone who becomes pregnant while virologically suppressed on long-acting cabotegravir and rilpivirine.

Released: October 21, 2022

Expiration: October 20, 2023

Begin Activity

Share

Faculty

William R. Short

William R. Short, MD, MPH, AAHIVS

Associate Professor of Medicine
Division of Infectious Diseases
Department of Medicine
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

ViiV Healthcare

Faculty Disclosure

Primary Author

William R. Short, MD, MPH, AAHIVS

Associate Professor of Medicine
Division of Infectious Diseases
Department of Medicine
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania